FDAnews
www.fdanews.com/articles/87668-novartis-pharma-obtains-additional-approval-for-its-proprietary-immunosuppressant-neoral

NOVARTIS PHARMA OBTAINS ADDITIONAL APPROVAL FOR ITS PROPRIETARY IMMUNOSUPPRESSANT NEORAL

June 19, 2006

Novartis Pharma has obtained additional approval for Neoral (cyclosporine), its proprietary immunosuppressant, from the Ministry of Health, Labor and Welfare.
JCN Network